webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Azido-PEG1-Val-Cit-OH

  CAS No.:   Cat No.: BADC-01220   Purity: ≥95% 4.5  

Azido-PEG1-Val-Cit-OH is a versatile ADC linker with azide functionality and Val-Cit dipeptide for enzymatic cleavage. Ideal for bioorthogonal conjugation and selective payload release in antibody-drug conjugate development.

Azido-PEG1-Val-Cit-OH

Structure of

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C16H29N7O6
Molecular Weight
415.44
Shipping
Room temperature, or blue ice upon request.
Storage
Store at -20 °C, keep in dry and avoid sunlight.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
IUPAC Name
Solubility
10 mm in DMSO
Shelf Life
-20°C 3 years powder; -80°C 2 years in solvent
Shipping
Room temperature, or blue ice upon request.
Storage
Store at -20 °C, keep in dry and avoid sunlight.

Azido-PEG1-Val-Cit-OH, a versatile linker compound utilized in bioconjugation and drug delivery systems, finds diverse applications. Here are four key applications:

Antibody-Drug Conjugates (ADCs): Employing Azido-PEG1-Val-Cit-OH as a pivotal linker in ADC synthesis, researchers craft targeted therapies for cancer by merging antibodies with cytotoxic drugs. This sophisticated linker ensures steadfast attachment of the drug to the antibody, enabling controlled release upon binding to the cancer cell target.

Proteomics: Within the realm of proteomics research, Azido-PEG1-Val-Cit-OH serves as a valuable tool for labeling proteins with fluorescent tags or other probes. This labeling strategy enables scrutiny of protein interactions, modifications, and functions within intricate biological systems. The cleavable nature of the linker facilitates the isolation of labeled proteins, paving the way for in-depth analysis and deeper insights into cellular processes.

Site-Specific Bioconjugation: Azido-PEG1-Val-Cit-OH facilitates precise bioconjugation through “click chemistry,” a bio-orthogonal reaction enabling targeted attachment of therapeutic agents, imaging probes, or functional molecules to specific biomolecules. This unparalleled specificity is essential for the development of precision-targeted therapies and advanced diagnostic tools.

Drug Delivery Systems: Fostering innovation in drug delivery systems, Azido-PEG1-Val-Cit-OH plays a pivotal role in designing sophisticated nanoparticles and polymer-drug conjugates. This versatile linker ensures stable drug incorporation within the delivery vehicle, enabling controlled release in response to specific cellular cues. By enhancing drug solubility, bioavailability, and targeted delivery to diseased tissues, this approach revolutionizes drug delivery, promising optimized therapeutic outcomes.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Methylcyclopropene-PEG4-NHS | Boc-Cystamine-Poc | Amino-PEG6-t-butyl ester | Azido-PEG1-Val-Cit-OH
Send Inquiry
Verification code
Inquiry Basket